Cipla gets Establishment Inspection Report from USFDA; stock down ~1%

Cipla gets Establishment Inspection Report from USFDA; stock down ~1%

Shares of Cipla slipped nearly 1% on the BSE in morning trade. The company has received an Establishment Inspection Report (EIR), indicating closure of the inspection after the USFDA inspected Patalganga manufacturing facility of the company from November 4, 2019, to November 13, 2019.


The inspection was carried out by the USFDA at the Patalganga manufacturing facility of the Company from November 4, 2019, to November 13, 2019, the company has received the Establishment Inspection Report (EIR), indicating closure of the inspection,” as per the filing.

Stock view:
Cipla Ltd is currently trading at Rs478.75, down by Rs1.5 or 0.31% from its previous closing of Rs480.25 on the BSE.

The scrip opened at Rs483.40 and has touched a high and low of Rs483.40 and Rs476.90 respectively.




About Gosip4U

Gosip4U is the digital wing of india - India's leading media and communications group with its interests spanning across country.

0 comments:

Post a Comment

Please add comment